Etco2 Levels on the End-tidal Concentration of Sevoflurane
NCT ID: NCT05778968
Last Updated: 2024-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2023-02-01
2024-07-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Measurements of End-tidal Carbondioxide Levels
NCT03923283
End Tidal Control of Sevoflurane
NCT02676934
Modeling the Effect of EtCO2 on Cerebral Oxygenation
NCT02284763
Comparison of the Effects of Oxycodone Versus Fentanyl on Airway Reflex to Tracheal Extubation and Postoperative Pain
NCT03204045
Comparing Endotracheal Tube Cuff Pressure in Laparoscopic Abdominal Surgery: Saline vs. Air Inflation
NCT06089187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
. Many pharmacological factors have been associated with alterations in MAC and Mac derivatives such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and anesthetics.
However, few studies have focused on physiological factors, such as hypercarbia or hypocarbia. A correlation has been found between Paco2 and Etco2 in ventilated patients with healthy lungs. Some authors have suggested that Etco2 could be considered appropriate for estimating Paco2 even in critical patients. Knowledge of the effects of Paco2 on end tidal concentration of sevoflurane among patients undergoing laparoscopic cholecystectomy may help anaesthesiologists titrate sevoflurane carefully and precisely during different mechanical ventilation settings to avoid dose-dependent hypotension, impaired cardiac contractility, and hypothermia caused by excessive anaesthetic depth of sevoflurane.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low ETCO2
low etco2
Etco2 levels will be adjusted at levels ranging between 25 mm Hg and 30 mm Hg
normal ETCO2
normal etco2
Etco2 levels will be adjusted at levels ranging between 31 mm Hg and 40 mm Hg
high ETCO2
high etco2
Etco2 levels will be adjusted at levels ranging between 41 mm Hg and 45 mm Hg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
low etco2
Etco2 levels will be adjusted at levels ranging between 25 mm Hg and 30 mm Hg
normal etco2
Etco2 levels will be adjusted at levels ranging between 31 mm Hg and 40 mm Hg
high etco2
Etco2 levels will be adjusted at levels ranging between 41 mm Hg and 45 mm Hg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted for laparoscopic cholecystectomy
Exclusion Criteria
* Patients with renal or liver dysfunction.
* Patients with chronic pain other than cholelithiasis.
* Cardiac disorders as uncontrolled hypertension, arrhythmia, Ischaemic heart disease, valvular heart disease and pulmonary hypertension.
* Patient with haematological disorder as Sickle cell disease.
* Chest patient as asthma, COPD.
* Combined surgery .
* History of allergy to any of the study drugs.
* Patients with communication problems, cognitive dysfunction, or psychological disorders.
* Patients who received analgesics or sedatives 24 h before a scheduled surgery.
* Alcohol or drug abuse.
30 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
tarek abdel hay mostafa
principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
thanaa elnomany, MD
Role: STUDY_DIRECTOR
tanta university, faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
tarek Abdelhay Mostafa
Tanta, El Gharbyia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MAC of sevoflurane
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.